MGTX
MeiraGTx Holdings PLC
NASDAQ: MGTX · HEALTHCARE · BIOTECHNOLOGY
$9.79
-5.96% today
Updated 2026-06-05
Market cap
$833.49M
P/E ratio
—
P/S ratio
10.45x
EPS (TTM)
$-1.48
Dividend yield
—
52W range
$6 – $12
Volume
0.9M
MeiraGTx Holdings PLC (MGTX) Insider transactions
Net insider activity
Net buying (490,837 shares)
Buy transactions
40
Sell transactions
60
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-27 | GIROUX, RICHARD | CFO & COO | Sale | 7,000 | — | — |
| 2026-05-19 | FORBES, ALEXANDRIA | Director, PRESIDENT & CEO | Sale | 62,000 | $9.17 | $568540.00 |
| 2026-05-13 | FLECK, PENNY RENEE | CHIEF DEVELOPMENT OFFICER | Buy | 100,000 | — | — |
| 2026-05-13 | FLECK, PENNY RENEE | CHIEF DEVELOPMENT OFFICER | Buy | 100,000 | — | — |
| 2026-04-21 | GIROUX, RICHARD | CFO & COO | Sale | 56,000 | $10.22 | $572320.00 |
| 2026-04-17 | PERCEPTIVE, ADVISORS LLC | Director, 10% Owner | Buy | 555,555 | $9.00 | $5.00M |
| 2026-04-07 | NAYLOR, STUART | CHIEF DEV. OFFICER | Sale | 27,661 | $9.36 | $258906.96 |
| 2026-03-25 | PERCEPTIVE, ADVISORS LLC | Director, 10% Owner | Buy | 400,000 | — | — |
| 2026-03-25 | PERCEPTIVE, ADVISORS LLC | Director, 10% Owner | Buy | 300,000 | — | — |
| 2026-03-24 | FORBES, ALEXANDRIA | Director, PRESIDENT & CEO | Sale | 62,000 | $7.41 | $459420.00 |
| 2026-02-21 | ZELDIN, ROBERT K | CHIEF MEDICAL OFFICER | Sale | 7,500 | — | — |
| 2026-02-21 | ZELDIN, ROBERT K | CHIEF MEDICAL OFFICER | Buy | 7,500 | — | — |
| 2026-02-21 | ZELDIN, ROBERT K | CHIEF MEDICAL OFFICER | Sale | 2,952 | $7.45 | $21992.40 |
| 2026-02-21 | WOLLIN, ROBERT J | GENERAL COUNSEL AND SECRETARY | Sale | 11,250 | — | — |
| 2026-02-21 | WOLLIN, ROBERT J | GENERAL COUNSEL AND SECRETARY | Buy | 11,250 | — | — |
| 2026-02-21 | WOLLIN, ROBERT J | GENERAL COUNSEL AND SECRETARY | Sale | 5,949 | $7.45 | $44320.05 |
| 2026-02-21 | NAYLOR, STUART | CHIEF DEV. OFFICER | Sale | 25,000 | — | — |
| 2026-02-21 | NAYLOR, STUART | CHIEF DEV. OFFICER | Buy | 25,000 | — | — |
| 2026-02-21 | NAYLOR, STUART | CHIEF DEV. OFFICER | Sale | 11,750 | $7.45 | $87537.50 |
| 2026-02-21 | GIROUX, RICHARD | CFO & COO | Sale | 60,000 | — | — |
| 2026-02-21 | GIROUX, RICHARD | CFO & COO | Buy | 60,000 | — | — |
| 2026-02-21 | GIROUX, RICHARD | CFO & COO | Sale | 31,726 | $7.45 | $236358.70 |
| 2026-02-21 | FORBES, ALEXANDRIA | Director, PRESIDENT & CEO | Sale | 62,500 | — | — |
| 2026-02-21 | FORBES, ALEXANDRIA | Director, PRESIDENT & CEO | Buy | 62,500 | — | — |
| 2026-02-21 | FORBES, ALEXANDRIA | Director, PRESIDENT & CEO | Sale | 33,048 | $7.45 | $246207.60 |
| 2026-01-17 | ZELDIN, ROBERT K | CHIEF MEDICAL OFFICER | Sale | 35,000 | — | — |
| 2026-01-17 | ZELDIN, ROBERT K | CHIEF MEDICAL OFFICER | Buy | 35,000 | — | — |
| 2026-01-17 | ZELDIN, ROBERT K | CHIEF MEDICAL OFFICER | Sale | 13,951 | $7.42 | $103516.42 |
| 2026-01-17 | WOLLIN, ROBERT J | GENERAL COUNSEL AND SECRETARY | Sale | 50,000 | — | — |
| 2026-01-17 | WOLLIN, ROBERT J | GENERAL COUNSEL AND SECRETARY | Buy | 50,000 | — | — |
| 2026-01-17 | WOLLIN, ROBERT J | GENERAL COUNSEL AND SECRETARY | Sale | 27,206 | $7.42 | $201868.52 |
| 2026-01-17 | NAYLOR, STUART | CHIEF DEV. OFFICER | Sale | 75,000 | — | — |
| 2026-01-17 | NAYLOR, STUART | CHIEF DEV. OFFICER | Buy | 75,000 | — | — |
| 2026-01-17 | NAYLOR, STUART | CHIEF DEV. OFFICER | Sale | 35,250 | $7.42 | $261555.00 |
| 2026-01-17 | GIROUX, RICHARD | CFO & COO | Sale | 310,000 | — | — |
| 2026-01-17 | GIROUX, RICHARD | CFO & COO | Buy | 310,000 | — | — |
| 2026-01-17 | GIROUX, RICHARD | CFO & COO | Sale | 163,916 | $7.42 | $1.22M |
| 2026-01-17 | FORBES, ALEXANDRIA | Director, PRESIDENT & CEO | Sale | 310,000 | — | — |
| 2026-01-17 | FORBES, ALEXANDRIA | Director, PRESIDENT & CEO | Buy | 310,000 | — | — |
| 2026-01-17 | FORBES, ALEXANDRIA | Director, PRESIDENT & CEO | Sale | 163,916 | $7.42 | $1.22M |
| 2026-01-07 | ZELDIN, ROBERT K | CHIEF MEDICAL OFFICER | Sale | 17,500 | — | — |
| 2026-01-07 | ZELDIN, ROBERT K | CHIEF MEDICAL OFFICER | Buy | 17,500 | — | — |
| 2026-01-07 | ZELDIN, ROBERT K | CHIEF MEDICAL OFFICER | Sale | 7,814 | $7.73 | $60402.22 |
| 2026-01-07 | ZELDIN, ROBERT K | CHIEF MEDICAL OFFICER | Sale | 6,729 | $7.73 | $52015.17 |
| 2026-01-07 | WOLLIN, ROBERT J | GENERAL COUNSEL AND SECRETARY | Sale | 7,500 | — | — |
| 2026-01-07 | WOLLIN, ROBERT J | GENERAL COUNSEL AND SECRETARY | Buy | 7,500 | — | — |
| 2026-01-07 | WOLLIN, ROBERT J | GENERAL COUNSEL AND SECRETARY | Sale | 4,364 | $7.73 | $33733.72 |
| 2026-01-07 | NAYLOR, STUART | CHIEF DEV. OFFICER | Sale | 37,500 | — | — |
| 2026-01-07 | NAYLOR, STUART | CHIEF DEV. OFFICER | Buy | 37,500 | — | — |
| 2026-01-07 | NAYLOR, STUART | CHIEF DEV. OFFICER | Sale | 17,625 | $7.73 | $136241.25 |
| 2026-01-07 | GIROUX, RICHARD | CFO & COO | Sale | 52,500 | — | — |
| 2026-01-07 | GIROUX, RICHARD | CFO & COO | Buy | 52,500 | — | — |
| 2026-01-07 | GIROUX, RICHARD | CFO & COO | Sale | 28,822 | $7.73 | $222794.06 |
| 2026-01-07 | FORBES, ALEXANDRIA | Director, PRESIDENT & CEO | Sale | 62,500 | — | — |
| 2026-01-07 | FORBES, ALEXANDRIA | Director, PRESIDENT & CEO | Buy | 62,500 | — | — |
| 2026-01-07 | FORBES, ALEXANDRIA | Director, PRESIDENT & CEO | Sale | 34,074 | $7.73 | $263392.02 |
| 2025-12-31 | PERCEPTIVE, ADVISORS LLC | Director, 10% Owner | Sale | 2,300,000 | $7.91 | $18.19M |
| 2025-12-23 | FORBES, ALEXANDRIA | Director, PRESIDENT & CEO | Sale | 6,250 | — | — |
| 2025-11-20 | WOLLIN, ROBERT J | GENERAL COUNSEL AND SECRETARY | Sale | 5,000 | — | — |
| 2025-10-21 | GIROUX, RICHARD | CFO & COO | Sale | 24,000 | $8.87 | $212880.00 |
| 2025-10-07 | FORBES, ALEXANDRIA | Director, PRESIDENT & CEO | Sale | 47,500 | $8.39 | $398525.00 |
| 2025-07-22 | GIROUX, RICHARD | CFO & COO | Sale | 24,000 | $8.52 | $204480.00 |
| 2025-07-08 | FORBES, ALEXANDRIA | Director, PRESIDENT & CEO | Sale | 47,500 | $7.97 | $378575.00 |
| 2025-06-30 | GIROUX, RICHARD | CFO & COO | Sale | 5,000 | — | — |
| 2025-06-12 | YU, DEBRA | Director | Buy | 45,000 | — | — |
| 2025-06-12 | SHENK, THOMAS E | Director | Buy | 45,000 | — | — |
| 2025-06-12 | SELIGMAN, NICOLE | Director | Buy | 45,000 | — | — |
| 2025-06-12 | PERCEPTIVE, ADVISORS LLC | Director, 10% Owner | Buy | 45,000 | — | — |
| 2025-06-12 | MENDOZA, NEIL | Director | Buy | 45,000 | — | — |
| 2025-06-12 | HUKKELHOVEN, ELLEN | Director | Buy | 45,000 | — | — |
| 2025-06-12 | HARRIS, KEITH R. | Director | Buy | 75,000 | — | — |
| 2025-06-12 | HARRIS, KEITH R. | Director | Buy | 45,000 | — | — |
| 2025-06-06 | HARRIS, KEITH R. | Director | Sale | 75,000 | — | — |
| 2025-06-06 | HARRIS, KEITH R. | Director | Buy | 75,000 | — | — |
| 2025-04-22 | GIROUX, RICHARD | CFO & COO | Sale | 24,000 | $6.00 | $144000.00 |
| 2025-04-08 | FORBES, ALEXANDRIA | Director, PRESIDENT & CEO | Sale | 47,500 | $5.34 | $253650.00 |
| 2025-04-03 | ZELDIN, ROBERT K | CHIEF MEDICAL OFFICER | Buy | 90,000 | — | — |
| 2025-04-03 | WOLLIN, ROBERT J | GENERAL COUNSEL AND SECRETARY | Buy | 100,000 | — | — |
| 2025-04-03 | NAYLOR, STUART | CHIEF DEV. OFFICER | Buy | 100,000 | — | — |
| 2025-04-03 | GIROUX, RICHARD | CFO & COO | Buy | 950,000 | — | — |
| 2025-04-03 | FORBES, ALEXANDRIA | Director, PRESIDENT & CEO | Buy | 950,000 | — | — |
| 2025-02-21 | ZELDIN, ROBERT K | CHIEF MEDICAL OFFICER | Sale | 15,000 | — | — |
| 2025-02-21 | ZELDIN, ROBERT K | CHIEF MEDICAL OFFICER | Buy | 15,000 | — | — |
| 2025-02-21 | ZELDIN, ROBERT K | CHIEF MEDICAL OFFICER | Sale | 5,903 | $7.30 | $43091.90 |
| 2025-02-21 | WOLLIN, ROBERT J | GENERAL COUNSEL AND SECRETARY | Sale | 22,500 | — | — |
| 2025-02-21 | WOLLIN, ROBERT J | GENERAL COUNSEL AND SECRETARY | Buy | 22,500 | — | — |
| 2025-02-21 | WOLLIN, ROBERT J | GENERAL COUNSEL AND SECRETARY | Sale | 12,116 | $7.30 | $88446.80 |
| 2025-02-21 | NAYLOR, STUART | CHIEF DEV. OFFICER | Sale | 50,000 | — | — |
| 2025-02-21 | NAYLOR, STUART | CHIEF DEV. OFFICER | Buy | 50,000 | — | — |
| 2025-02-21 | NAYLOR, STUART | CHIEF DEV. OFFICER | Sale | 23,500 | $7.30 | $171550.00 |
| 2025-02-21 | GIROUX, RICHARD | CFO & COO | Sale | 120,000 | — | — |
| 2025-02-21 | GIROUX, RICHARD | CFO & COO | Buy | 120,000 | — | — |
| 2025-02-21 | GIROUX, RICHARD | CFO & COO | Sale | 63,452 | $7.30 | $463199.60 |
| 2025-02-21 | FORBES, ALEXANDRIA | Director, PRESIDENT & CEO | Sale | 125,000 | — | — |
| 2025-02-21 | FORBES, ALEXANDRIA | Director, PRESIDENT & CEO | Buy | 125,000 | — | — |
| 2025-02-21 | FORBES, ALEXANDRIA | Director, PRESIDENT & CEO | Sale | 66,095 | $7.30 | $482493.50 |
| 2025-01-21 | GIROUX, RICHARD | CFO & COO | Sale | 24,000 | $6.29 | $150960.00 |
| 2025-01-14 | ZELDIN, ROBERT K | CHIEF MEDICAL OFFICER | Sale | 37,500 | — | — |
| 2025-01-14 | ZELDIN, ROBERT K | CHIEF MEDICAL OFFICER | Buy | 37,500 | — | — |
| 2025-01-14 | ZELDIN, ROBERT K | CHIEF MEDICAL OFFICER | Sale | 15,149 | $5.77 | $87409.73 |
Frequently asked questions
Are MGTX insiders buying or selling?
Over the transactions on record, MGTX insiders have been net sellers, with about $27.54M in stock sold across 60 sales, against 1 open-market purchase.
Does insider selling at MGTX mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.
Which MGTX insiders are selling the most?
Recent selling is concentrated in a few names. PERCEPTIVE, ADVISORS LLC accounts for the largest share on record, with about $18.19M sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.